secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neuraxis, INC (NRXS)
CIK:        0001933567
Form:       8-K
Filed at:   2024-11-21T23:59:59+00:00
Accession:  0001493152-24-047196
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neuraxis amends Series B Preferred terms: extends dividends, increases authorized shares, revises voting rights
--------------------------------------------------------------------------------

- Increased authorized Series B Preferred shares from 4,000,000 to 5,000,000.
- Extended 8.5% annual dividend right by 18 months, now through December 31, 2026.
- Amended voting rights: each Series B share votes equal to common shares convertible at $3.80 per share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1933567/000149315224047196/0001493152-24-047196-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1933567/000149315224047196/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-047196

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer